SYRE 8-K 2026-10-07

Spyre Therapeutics, Inc. (SYRE) 8-K dated 2026-10-07 — accession 0001628280-26-065291. This URL is the filing, not the SYRE hub.

Spyre Therapeutics, Inc. (SYRE) is a biotechnology company listed on NASDAQ.

Spyre Therapeutics, Inc. filed a 8-K on 2026-10-07. Accession 0001628280-26-065291.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.

Not investment advice. The SYRE SEC hub lists recent forms. The stock page is the research view.